scholarly article | Q13442814 |
P50 | author | Lawrence Corey | Q6503944 |
Michael Boeckh | Q56072917 | ||
Meei-Li Huang | Q61713476 | ||
Wendy Leisenring | Q75026076 | ||
Danielle M Zerr | Q100739238 | ||
P2093 | author name string | Jesse R Fann | |
Colleen Delaney | |||
Hu Xie | |||
David Breiger | |||
Amanda L Adler | |||
P2860 | cites work | High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients | Q58473705 |
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers | Q73427004 | ||
Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients | Q80141489 | ||
The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement | Q28203897 | ||
Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging | Q33375328 | ||
The Delirium Rating Scale. Its use in consultation-liaison research | Q33643269 | ||
Identifying meaningful intra-individual change standards for health-related quality of life measures | Q33916167 | ||
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples | Q33960980 | ||
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences | Q34583041 | ||
Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant | Q35801726 | ||
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation | Q36095851 | ||
Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation | Q36727466 | ||
1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. | Q40613007 | ||
Human herpesvirus 6 limbic encephalitis after stem cell transplantation | Q43798251 | ||
Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients | Q43843926 | ||
Delirium in patients undergoing hematopoietic stem cell transplantation | Q44197109 | ||
Impact of human herpesvirus-6 after haematopoietic stem cell transplantation | Q44872903 | ||
The delirium rating scale in children and adolescents | Q46604849 | ||
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. | Q48110777 | ||
Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid | Q48318086 | ||
Clinical presentation of delirium in patients undergoing hematopoietic stem cell transplantation | Q48566891 | ||
The Children's Orientation and Amnesia Test: relationship to severity of acute head injury and to recovery of memory | Q48864604 | ||
Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation. | Q50905386 | ||
A symptom rating scale for delirium. | Q52071753 | ||
Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. | Q53577416 | ||
Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. | Q53633777 | ||
Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. | Q53646005 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | delirium | Q160796 |
cell biology | Q7141 | ||
P304 | page(s) | 5243-9 | |
P577 | publication date | 2011-05-12 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients | |
P478 | volume | 117 |
Q34273968 | Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. |
Q38116092 | Biomarkers of delirium as a clue to diagnosis and pathogenesis of Wernicke-Korsakoff syndrome |
Q60921241 | Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults |
Q37952634 | Chromosomally integrated human herpesvirus 6: questions and answers |
Q37982856 | Chromosomally integrated human herpesvirus-6 in transplant recipients |
Q59356776 | Comparison of HHV-6 DNA detection in plasma and whole blood in allogeneic hematopoietic stem cell transplant recipients: frequent false-positive results for active HHV-6 infection using whole blood samples |
Q54252789 | Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology. |
Q37276889 | Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. |
Q35752239 | Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults |
Q36834718 | Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR. |
Q40185839 | Development of real-time RT-PCR assays for detection of three classes of HHV-6A gene transcripts. |
Q30883059 | Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation |
Q27345284 | Early developmental outcomes of children with congenital HHV-6 infection |
Q33559473 | Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation |
Q84507133 | Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis |
Q33897804 | Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin |
Q92993210 | Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation |
Q38045704 | HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis |
Q41073087 | HHV-6 encephalitis may complicate the early phase after allogeneic hematopoietic stem cell transplantation: Detection by qualitative multiplex PCR and subsequent quantitative real-time PCR. |
Q28727925 | HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation |
Q27010284 | Human Herpesvirus-6 Encephalitis After Hematopoietic Stem Cell Transplantation |
Q43971471 | Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study |
Q34195389 | Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation. |
Q41715322 | Human herpesvirus 6 is associated with status epilepticus and hyponatremia after umbilical cord blood transplantation |
Q35801310 | Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation |
Q38444117 | Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. |
Q48178536 | Human herpesvirus-6 encephalitis following chemotherapy induction for acute myelogenous leukemia |
Q41021152 | Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation |
Q35879617 | Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. |
Q26827409 | Immune response to HHV-6 and implications for immunotherapy |
Q37006823 | Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation |
Q35482603 | Laboratory and clinical aspects of human herpesvirus 6 infections |
Q92111619 | Long-term Outcomes of Patients With Human Herpesvirus 6 Encephalitis |
Q38002109 | Molecular diagnosis and management of viral infections in hematopoietic stem cell transplant recipients |
Q40264216 | New rising infection: human herpesvirus 6 is frequent in myeloma patients undergoing autologous stem cell transplantation after induction therapy with bortezomib |
Q37189313 | Persistent human herpesvirus-6 infection in patients with an inherited form of the virus |
Q91345168 | Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation |
Q37954124 | Psychosocial care in cancer |
Q34537814 | Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals |
Q38256992 | Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials |
Q44994852 | Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation |
Q54296983 | Specific CD8⁺ T cells recognize human herpesvirus 6B. |
Q36236659 | TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes |
Search more.